Claire Dossier Selected Research

Claire Dossier Research Topics

Disease

16	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2023 - 11/2016
3	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 01/2022
3	Proteinuria 01/2022 - 01/2017
3	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 05/2020
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2024 - 11/2019
2	Infections 01/2017 - 12/2014
1	Thrombotic Thrombocytopenic Purpura 05/2024
1	Body Weight (Weight, Body) 05/2024
1	Thrombocytopenia (Thrombopenia) 05/2024
1	Atypical Hemolytic Uremic Syndrome 04/2024
1	Hemolytic-Uremic Syndrome 04/2024
1	Neoplasms (Cancer) 12/2023
1	Thrombotic Microangiopathies 11/2023
1	Kidney Diseases (Kidney Disease) 11/2023
1	Hemorrhage 01/2023
1	Vasculitis (Vasculitides) 01/2023
1	Turner Syndrome (Turner's Syndrome) 12/2022
1	Pathologic Complete Response 01/2022
1	Disease Progression 01/2022
1	Neutropenia 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2022
1	Human Influenza (Influenza) 05/2020
1	Bartter Syndrome (Syndrome, Bartter) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2017
1	Narcolepsy 03/2017
1	Anemia 06/2016
1	Neurologic Manifestations (Neurological Manifestations) 08/2013
1	Hypertension (High Blood Pressure) 08/2013

Drug/Important Bio-Agent (IBA)

9	SteroidsIBA 12/2023 - 11/2016
8	Rituximab (Mabthera)FDA Link 02/2024 - 01/2017
3	AutoantibodiesIBA 04/2024 - 01/2018
3	daratumumabIBA 02/2024 - 01/2021
3	obinutuzumabIBA 12/2023 - 01/2021
3	AntibodiesIBA 01/2022 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2022 - 12/2014
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 03/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
1	thiamine triphosphorate (TTP)IBA 05/2024
1	Complement Factor H (Factor H)IBA 04/2024
1	Immunoglobulins (Immunoglobulin)IBA 11/2023
1	Complement System Proteins (Complement)IBA 11/2023
1	chemotactic factor inactivatorIBA 11/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	Fc(alpha) receptorIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	galactosyl-deficient IgA1IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Inactivated VaccinesIBA 05/2020
1	VaccinesIBA 05/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020
1	Opsonin Proteins (Opsonins)IBA 05/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020
1	Apolipoprotein L1IBA 11/2019
1	SaltsIBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	AntigensIBA 01/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2016
1	EnzymesIBA 06/2016
1	Immunoglobulin M (IgM)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	Nicardipine (Dagan)FDA LinkGeneric 08/2013

Therapy/Procedure

5	Therapeutics 05/2024 - 03/2017
1	Plasma Exchange 04/2024
1	Transplantation 01/2023
1	CARE protocol 12/2022
1	Glycemic Control 11/2017